首页 > 最新文献

Journal de pharmacie de Belgique最新文献

英文 中文
[Reliability of OTC advertisement Relevance and quality of cited literature]. 【非处方药广告的可靠性、相关性与被引文献质量】。
Pub Date : 2016-09-01
L Claes, V De Vylder, L De Stercke, I Muyshondt, S Schotte, A Van Hooimissen, N Van Paemel, E Mehuys, K J Boussery

Introduction Pharmacist receive a lot of publicity for OTC products. Often one or more literature references are mentioned to support the advertising claims. Objective In this study we examine: [1) whether the advertising claim is consistent with what is stated in the literature references mentioned on the leaflet and [2] whether these literature references are trustworthy. Method Through 60 randomly selected community pharmacies, pharmacist-directed advertisements for OTC products I= medicines, medical devices, dietary supplements and parapharmacy) with at least one bibliographic reference, were collected. The literature references listed in these leaflets were assessed in terms of content [= is the claim consistent with the information in the reference) and technically [= evaluation of the quality of the references]. Results The 85 collected OTC advertisements made 214 claims that referred to 243 references. Of these, 128 references did not support the promotional claim. The remaining 84 references did support the corresponding claim. From 31 references no full text was obtained. Of the 84 supporting references 44 were of dubious quality. The remaining 40 references were found to be reliable. Conclusion This study shows that the literature references in advertising leaflets for OTC-products are not a reliable source of information on the advertised product. Pharmacists should deal critically with this information and should be encouraged to consult reliable scientific sources.

药剂师收到了很多关于非处方药的宣传。通常会提到一个或多个文献文献来支持广告的说法。在本研究中,我们检验:[1]广告声称是否与宣传单上提及的文献中所述的内容一致;[2]这些文献是否可信。方法随机抽取60家社区药店,收集药师指导的非处方药(药品、医疗器械、膳食补充剂和副药)至少有一篇参考文献的广告。对这些宣传单中列出的文献参考文献进行了内容评估[=是否声明与参考文献中的信息一致]和技术评估[=对参考文献质量的评估]。结果85份收集到的非处方药广告共214条,引用文献243篇。其中,128份参考资料不支持促销主张。其余84条参考文献确实支持相应的主张。从31篇参考文献中没有得到全文。在84个支持参考文献中,有44个质量可疑。其余40篇文献被认为是可靠的。结论本研究表明,非处方药广告宣传单上的文献资料并不是广告产品的可靠信息来源。药剂师应审慎对待这些信息,并应鼓励他们咨询可靠的科学来源。
{"title":"[Reliability of OTC advertisement Relevance and quality of cited literature].","authors":"L Claes,&nbsp;V De Vylder,&nbsp;L De Stercke,&nbsp;I Muyshondt,&nbsp;S Schotte,&nbsp;A Van Hooimissen,&nbsp;N Van Paemel,&nbsp;E Mehuys,&nbsp;K J Boussery","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Introduction Pharmacist receive a lot of publicity for OTC products. Often one or more literature references are mentioned to support the advertising claims. Objective In this study we examine: [1) whether the advertising claim is consistent with what is stated in the literature references mentioned on the leaflet and [2] whether these literature references are trustworthy. Method Through 60 randomly selected community pharmacies, pharmacist-directed advertisements for OTC products I= medicines, medical devices, dietary supplements and parapharmacy) with at least one bibliographic reference, were collected. The literature references listed in these leaflets were assessed in terms of content [= is the claim consistent with the information in the reference) and technically [= evaluation of the quality of the references]. Results The 85 collected OTC advertisements made 214 claims that referred to 243 references. Of these, 128 references did not support the promotional claim. The remaining 84 references did support the corresponding claim. From 31 references no full text was obtained. Of the 84 supporting references 44 were of dubious quality. The remaining 40 references were found to be reliable. Conclusion This study shows that the literature references in advertising leaflets for OTC-products are not a reliable source of information on the advertised product. Pharmacists should deal critically with this information and should be encouraged to consult reliable scientific sources.</p>","PeriodicalId":14736,"journal":{"name":"Journal de pharmacie de Belgique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36594230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Polymedication among elderly patients Preventing drug related problems and inappropriate medication]. 老年患者多重用药预防药物相关问题及用药不当
Pub Date : 2016-09-01
S Patris

Polypharmacy is a common phenomenon among elderly patients. A simultaneous intake of a large number of drugs can possibly lead to drug-related problems due to an increased risk of drug interactions, medication errors, contra-indications, but also a lack of patient compliance. Elderly patients are particularlyvulnerable because of physiological and pathological aging. Therefore we need to be particularly attentive to their medication, especially in case of polypharmacy. A systematic review of the medication for elderly patients should regularly be performed to prevent the occurrence of potentially drug-related problems. In view of his central role in the dispensing of medicines, the pharmacist can carry out this medication review in consultation with the treating physician.

多药是老年患者中常见的现象。同时摄入大量药物可能会导致药物相关问题,因为药物相互作用、用药错误、禁忌症的风险增加,而且患者缺乏依从性。由于生理性和病理性老化,老年患者特别容易受到伤害。因此,我们需要特别注意他们的用药,特别是在多种药物的情况下。应定期对老年患者的用药进行系统回顾,以防止潜在的药物相关问题的发生。鉴于他在配药中的核心作用,药剂师可以在与治疗医生协商的情况下进行药物审查。
{"title":"[Polymedication among elderly patients Preventing drug related problems and inappropriate medication].","authors":"S Patris","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Polypharmacy is a common phenomenon among elderly patients. A simultaneous intake of a large number of drugs can possibly lead to drug-related problems due to an increased risk of drug interactions, medication errors, contra-indications, but also a lack of patient compliance. Elderly patients are particularlyvulnerable because of physiological and pathological aging. Therefore we need to be particularly attentive to their medication, especially in case of polypharmacy. A systematic review of the medication for elderly patients should regularly be performed to prevent the occurrence of potentially drug-related problems. In view of his central role in the dispensing of medicines, the pharmacist can carry out this medication review in consultation with the treating physician.</p>","PeriodicalId":14736,"journal":{"name":"Journal de pharmacie de Belgique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36594227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A practical program for outpatient parenteral antimicrobial therapy]. 【门诊静脉外抗菌药物治疗实用方案】。
Pub Date : 2016-09-01
T Ravelingien, F Buyle, S Deryckere, D Huis In 't Veld, M Debrauwere, K Verplancke, S Callens, S Commeyne, C Pattyn, A Somers, D Vogelaers

Some infections require prolonged parenteral antimicrobial therapy, which can be continued in an outpatient setting. The Ghent University Hospital has fifteen years of experience with Outpatient Parenteral Antimicrobial Therapy [OPAT) in the patient own home setting. As a quality improvement initiative, this process was critically reviewed in a multidisciplinary approach. Several challenges and barriers were identified, including regulatory obstacles for OPAT in Belgium, such as Lack of uniformity in ambulatory reimbursement of parenteral antimicrobials. There is no financial incentive for the patient with OPAT, as costs for the patient of outpatient therapy can be higher as compared with hospitalization. Other barriers include delayed approval of the certificate for reimbursement, low availability of medicines in the community pharmacies and limited knowledge of the medical devices for administration in ambulatory setting. All critical steps in the revised OPAT program are summarized in a flowchart with a checklist for all stakeholders. Firstly, a list with specific criteria to include patients in an OPAT program is provided. Secondly, the Multidisciplinary Infection Team received a formal mandate to review all eligible OPAT patients. In order to select the most appropriate catheter a decision tree was developed and standardized packages with medical devices were developed. Thirdly, patients receive oral and written information about the treatment with practical and financial implications. Fourthly, information is provided towards the general practitioners, community pharmacists and home care nurses. Standardization of the OPAT-program aims at improving quality and safety of intravenous antimicrobial therapy in the home setting.

有些感染需要长时间的肠外抗菌治疗,这可以在门诊继续进行。根特大学医院在患者自己的家庭环境中进行门诊肠外抗菌治疗(OPAT)已有15年的经验。作为一项质量改进倡议,该过程在多学科方法中进行了严格审查。确定了若干挑战和障碍,包括比利时OPAT的监管障碍,如静脉注射抗菌素的门诊报销缺乏统一。OPAT患者没有经济激励,因为门诊治疗患者的费用可能高于住院治疗。其他障碍包括延迟批准报销证书、社区药房药品供应不足以及对门诊管理医疗设备的了解有限。修订后的OPAT计划中的所有关键步骤都总结在流程图中,并附有所有利益攸关方的清单。首先,提供了一份包含OPAT项目中患者的具体标准的列表。其次,多学科感染小组收到了审查所有符合条件的OPAT患者的正式授权。为了选择最合适的导管,开发了一个决策树,并开发了标准化的医疗设备包。第三,患者接受有关治疗的口头和书面信息,这些信息具有实际和经济意义。第四,信息提供给全科医生,社区药剂师和家庭护理护士。opat计划的标准化旨在提高家庭环境中静脉注射抗菌药物治疗的质量和安全性。
{"title":"[A practical program for outpatient parenteral antimicrobial therapy].","authors":"T Ravelingien,&nbsp;F Buyle,&nbsp;S Deryckere,&nbsp;D Huis In 't Veld,&nbsp;M Debrauwere,&nbsp;K Verplancke,&nbsp;S Callens,&nbsp;S Commeyne,&nbsp;C Pattyn,&nbsp;A Somers,&nbsp;D Vogelaers","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Some infections require prolonged parenteral antimicrobial therapy, which can be continued in an outpatient setting. The Ghent University Hospital has fifteen years of experience with Outpatient Parenteral Antimicrobial Therapy [OPAT) in the patient own home setting. As a quality improvement initiative, this process was critically reviewed in a multidisciplinary approach. Several challenges and barriers were identified, including regulatory obstacles for OPAT in Belgium, such as Lack of uniformity in ambulatory reimbursement of parenteral antimicrobials. There is no financial incentive for the patient with OPAT, as costs for the patient of outpatient therapy can be higher as compared with hospitalization. Other barriers include delayed approval of the certificate for reimbursement, low availability of medicines in the community pharmacies and limited knowledge of the medical devices for administration in ambulatory setting. All critical steps in the revised OPAT program are summarized in a flowchart with a checklist for all stakeholders. Firstly, a list with specific criteria to include patients in an OPAT program is provided. Secondly, the Multidisciplinary Infection Team received a formal mandate to review all eligible OPAT patients. In order to select the most appropriate catheter a decision tree was developed and standardized packages with medical devices were developed. Thirdly, patients receive oral and written information about the treatment with practical and financial implications. Fourthly, information is provided towards the general practitioners, community pharmacists and home care nurses. Standardization of the OPAT-program aims at improving quality and safety of intravenous antimicrobial therapy in the home setting.</p>","PeriodicalId":14736,"journal":{"name":"Journal de pharmacie de Belgique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36594234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Capsaicinoids, capsaicin and capsicum oleoresin]. 辣椒素,辣椒素和辣椒油树脂。
Pub Date : 2016-09-01
M Van Steenkiste
{"title":"[Capsaicinoids, capsaicin and capsicum oleoresin].","authors":"M Van Steenkiste","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":14736,"journal":{"name":"Journal de pharmacie de Belgique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36594228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Bisacodyl as laxative in Belgian pharmacy]. [比利时药房中作为泻药的比沙可啶]。
Pub Date : 2016-06-01
K De Braekeleer, L Vandersteen

Obstipation is a common complaint in pharmacies and one of the treatment strategies is the delivery of enteric coated bisacodyL tablets. This article reviews the different aspects that are important for pharmacists to guarantee patient safety: whether medical treatment is required or not, which advice should be given on how to use the drug, and to conclude what is the analytical quality of the commercial products on the Belgian market.

便秘是药房常见的投诉,治疗策略之一是肠溶比沙丁片的递送。本文综述了药师保障患者安全的重要方面:是否需要医疗治疗,如何使用药物应给出哪些建议,并总结了比利时市场上商业产品的分析质量。
{"title":"[Bisacodyl as laxative in Belgian pharmacy].","authors":"K De Braekeleer,&nbsp;L Vandersteen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Obstipation is a common complaint in pharmacies and one of the treatment strategies is the delivery of enteric coated bisacodyL tablets. This article reviews the different aspects that are important for pharmacists to guarantee patient safety: whether medical treatment is required or not, which advice should be given on how to use the drug, and to conclude what is the analytical quality of the commercial products on the Belgian market.</p>","PeriodicalId":14736,"journal":{"name":"Journal de pharmacie de Belgique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36551850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Medication counselling and support with individual medication preparation for trail elderly living at home-preliminary results]. [为独居老人提供药物辅导及个别药物准备的支援-初步结果]。
Pub Date : 2016-06-01
S Liekens, L Zwaenepoel, M Van de Putte

Background Medication safety and adherence are important aspects of quality of life, especially for frail elderly in our society. However, many elderly living at home may experience difficulties when taking their medication, and are therefore at risk for medication- related problems. The current living lab was implemented within the framework of the Flanders Care Living Labs and set the objective to develop a care pathway to improve medication safety and adherence for elderly living at home. Automated Individual Medication Preparation [IMP] was provided by a community-pharmacist in order to support frail elderly in taking their medication more correctly and thereby improving adherence. Methods In a before and after study, each patient was supported for 13 weeks through a multidisciplinary care pathway. Key in this pathway was the shared medication schedule (between GP and pharmacist) as the starting point for IMP and medication counselling. The increased medication support based on IMP was evaluated in frail elderly (age a 65 years, complex medication scheme a 5 medicines and a 3 intakes / day) before and after the study, by measuring adherence and satisfaction with counselling and repackaging the medication in sachets. Results The preliminary results of the current study showed that the self-reported adherence rate in frail elderly was significantly higher (p <0.05) after implementation of the pharmacists' intervention with automated IMP. At the end of the study every patient indicated that the repackaging of the medication by dose was helpful in order to take their medication correctly. Conclusion Increased medication counselling with IMP by the community-pharmacist may be a useful aid and supporting tool for frail elderly living at home with a complex medication scheme.

用药安全性和依从性是生活质量的重要方面,特别是对我们社会中虚弱的老年人。然而,许多住在家里的老人在服药时可能会遇到困难,因此面临服药相关问题的风险。目前的生活实验室是在弗兰德斯护理生活实验室的框架内实施的,其目标是开发一种护理途径,以提高居家老年人的用药安全性和依从性。一名社区药剂师提供了自动个人药物准备(IMP),以支持体弱多病的老年人更正确地服用药物,从而提高依从性。方法在研究前后,通过多学科护理途径对每位患者进行13周的支持。这一途径的关键是共享用药时间表(GP和药剂师之间)作为IMP和用药咨询的起点。在研究前后,通过测量依从性和对咨询的满意度以及将药物重新包装成小袋,评估基于IMP的增加的药物支持在虚弱的老年人(65岁,复杂的药物方案,5种药物和3次服用/天)中进行。结果本研究的初步结果显示,体弱老年人自我报告的依从率明显较高(p
{"title":"[Medication counselling and support with individual medication preparation for trail elderly living at home-preliminary results].","authors":"S Liekens,&nbsp;L Zwaenepoel,&nbsp;M Van de Putte","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Background Medication safety and adherence are important aspects of quality of life, especially for frail elderly in our society. However, many elderly living at home may experience difficulties when taking their medication, and are therefore at risk for medication- related problems. The current living lab was implemented within the framework of the Flanders Care Living Labs and set the objective to develop a care pathway to improve medication safety and adherence for elderly living at home. Automated Individual Medication Preparation [IMP] was provided by a community-pharmacist in order to support frail elderly in taking their medication more correctly and thereby improving adherence. Methods In a before and after study, each patient was supported for 13 weeks through a multidisciplinary care pathway. Key in this pathway was the shared medication schedule (between GP and pharmacist) as the starting point for IMP and medication counselling. The increased medication support based on IMP was evaluated in frail elderly (age a 65 years, complex medication scheme a 5 medicines and a 3 intakes / day) before and after the study, by measuring adherence and satisfaction with counselling and repackaging the medication in sachets. Results The preliminary results of the current study showed that the self-reported adherence rate in frail elderly was significantly higher (p <0.05) after implementation of the pharmacists' intervention with automated IMP. At the end of the study every patient indicated that the repackaging of the medication by dose was helpful in order to take their medication correctly. Conclusion Increased medication counselling with IMP by the community-pharmacist may be a useful aid and supporting tool for frail elderly living at home with a complex medication scheme.</p>","PeriodicalId":14736,"journal":{"name":"Journal de pharmacie de Belgique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36551851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Standardisation of methods for dilution of intravenous medications in hospital]. 医院静脉注射药物稀释方法的标准化
Pub Date : 2016-06-01
J D Hecq, C H Vastrade, J Perrad, R Garcous, F Amant, C H Artoisenet, C Michel, C Pirlot, A Dive

Introduction The administration of intravenous medications in hospital is a common practice. Although it may seem almost insignificant, this practice remains no less an act which involves risks, due to many factors identified. It is therefore important to gather, clarify and communicate the updated information on the modalities of the administration of these injections in order to facilitate and secure the work of the teams of care with a view of an optimal and standardized administration of intravenous medications. Method The tables of standardization of injectable drugs have been made on several occasions in the past and distributed in the care units. The latest version of these documents was reviewed and updated in the light of the recent editions of several sources. The data concerning each individual injectable medicine have individual as well been systematically updates. The updated data have been integrated into the electronic prescription of medicines, a standardized dilution is now proposed by default to the prescriber. For some drugs, special modalities of administration have been planned to meet the specific needs of patients hospitalized in the Intensive Care Unit (ICU). Results The methods for dilution of injections in classical hospitalization have been integrated in the electronic prescribing software (238 "packages" in total. The specific dilutions used in the ICU (48 in total, have been validated but may not be used in the conventional care units. Conclusion All of the information relating to the methods of preparation and administration have been gathered and clarified in order to facilitate and secure the work of the teams of care and thus enable optimal administration of intravenous medications. The information is accessible on paper file and via the internal computer network, the PC of intensive care units and the software Computerized prescription.

医院静脉给药是一种常见的做法。虽然它看起来几乎微不足道,但由于确定了许多因素,这种做法仍然是一种涉及风险的行为。因此,重要的是收集、澄清和传达这些注射给药方式的最新信息,以便促进和确保护理小组的工作,以实现最佳和标准化的静脉注射给药。方法以往曾多次编制注射剂药品标准化表,并在各护理单位分发。这些文件的最新版本是根据几个来源的最新版本审查和增订的。每一种注射药物的数据都有单独和系统的更新。更新的数据已集成到电子处方中,现在默认向处方者建议标准化稀释。对于一些药物,已经计划了特殊的给药方式,以满足在重症监护病房(ICU)住院的患者的特殊需要。结果经典住院注射剂稀释方法已集成到电子处方软件中(共238个“包”)。ICU使用的特定稀释剂(总共48种)已经过验证,但不能用于常规护理病房。结论收集和整理了所有有关制剂和给药方法的资料,为护理小组的工作提供了方便和保障,从而实现静脉给药的优化。这些信息可以通过纸质文件、内部计算机网络、重症监护病房的个人电脑和计算机处方软件访问。
{"title":"[Standardisation of methods for dilution of intravenous medications in hospital].","authors":"J D Hecq,&nbsp;C H Vastrade,&nbsp;J Perrad,&nbsp;R Garcous,&nbsp;F Amant,&nbsp;C H Artoisenet,&nbsp;C Michel,&nbsp;C Pirlot,&nbsp;A Dive","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Introduction The administration of intravenous medications in hospital is a common practice. Although it may seem almost insignificant, this practice remains no less an act which involves risks, due to many factors identified. It is therefore important to gather, clarify and communicate the updated information on the modalities of the administration of these injections in order to facilitate and secure the work of the teams of care with a view of an optimal and standardized administration of intravenous medications. Method The tables of standardization of injectable drugs have been made on several occasions in the past and distributed in the care units. The latest version of these documents was reviewed and updated in the light of the recent editions of several sources. The data concerning each individual injectable medicine have individual as well been systematically updates. The updated data have been integrated into the electronic prescription of medicines, a standardized dilution is now proposed by default to the prescriber. For some drugs, special modalities of administration have been planned to meet the specific needs of patients hospitalized in the Intensive Care Unit (ICU). Results The methods for dilution of injections in classical hospitalization have been integrated in the electronic prescribing software (238 \"packages\" in total. The specific dilutions used in the ICU (48 in total, have been validated but may not be used in the conventional care units. Conclusion All of the information relating to the methods of preparation and administration have been gathered and clarified in order to facilitate and secure the work of the teams of care and thus enable optimal administration of intravenous medications. The information is accessible on paper file and via the internal computer network, the PC of intensive care units and the software Computerized prescription.</p>","PeriodicalId":14736,"journal":{"name":"Journal de pharmacie de Belgique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36551853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Care pathway for high urinary tract infection: an update in an emergency department of a French military hospital]. [高尿路感染的护理途径:法国一家军事医院急诊科的最新进展]。
Pub Date : 2016-06-01
A Baudouin, T Fontaine, I Carnal, P Gerome, C Lablanche, P Girard, C Dussart

Objectives Assessing the impact of professional practices on a patient's course is an interesting way to optimize health care pathway. The aim of our study is to update and evaluate the compliance to the recommendations of the Societe de Pathologie Infectieuse de Langue Francaise with regards to professional practices and the route of patients admitted to the emergency department of a French military hospital for high urinary tract infection. Patients and methods A retrospective study was carried out on patients admitted to the emergency department and treated for high urinary tract infection from January 1st, 2015 to April 30th, 2015. Clinical and administrative data, medical exams, and antibiotic prescriptions were extracted from computerized patient medical files and from emergency medical files. Results Out of 91 medical cares, 57% were compliant with the recommendations. For 60% of the patients, blood cultures were not argued and in 70% of cases, imaging wasn't justified. Antibiotic prescriptions were not compliant in 31% of cases, mostly due to long prescription durations. Two third of patients received outpatient care. All hospitalizations were argued. Conclusions Drawing up a caring protocol, regularly raising awareness to the good use of antibiotics, as well as reinforcing a cross disciplinary approach will allow optimizing health care pathways for patients coming to the emergency department with high urinary tract infection.

目的评估专业实践对患者病程的影响是优化医疗保健途径的一种有趣的方式。我们研究的目的是更新和评估法国语言病理感染协会关于专业实践和法国军队医院急诊科收治高尿路感染患者路线的建议的依从性。患者与方法回顾性分析2015年1月1日至2015年4月30日急诊科收治的高尿路感染患者。临床和行政数据、医学检查和抗生素处方提取自计算机化的患者医疗档案和急诊医疗档案。结果91家医疗机构中,57%的医疗机构符合建议。对于60%的患者,血培养没有争议,在70%的病例中,成像不合理。31%的病例抗生素处方不合规,主要是由于处方持续时间长。三分之二的患者接受了门诊治疗。所有住院治疗都是有争议的。结论制定护理方案,定期提高对抗生素良好使用的认识,并加强跨学科方法,将有助于优化急诊科高尿路感染患者的卫生保健途径。
{"title":"[Care pathway for high urinary tract infection: an update in an emergency department of a French military hospital].","authors":"A Baudouin,&nbsp;T Fontaine,&nbsp;I Carnal,&nbsp;P Gerome,&nbsp;C Lablanche,&nbsp;P Girard,&nbsp;C Dussart","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Objectives Assessing the impact of professional practices on a patient's course is an interesting way to optimize health care pathway. The aim of our study is to update and evaluate the compliance to the recommendations of the Societe de Pathologie Infectieuse de Langue Francaise with regards to professional practices and the route of patients admitted to the emergency department of a French military hospital for high urinary tract infection. Patients and methods A retrospective study was carried out on patients admitted to the emergency department and treated for high urinary tract infection from January 1st, 2015 to April 30th, 2015. Clinical and administrative data, medical exams, and antibiotic prescriptions were extracted from computerized patient medical files and from emergency medical files. Results Out of 91 medical cares, 57% were compliant with the recommendations. For 60% of the patients, blood cultures were not argued and in 70% of cases, imaging wasn't justified. Antibiotic prescriptions were not compliant in 31% of cases, mostly due to long prescription durations. Two third of patients received outpatient care. All hospitalizations were argued. Conclusions Drawing up a caring protocol, regularly raising awareness to the good use of antibiotics, as well as reinforcing a cross disciplinary approach will allow optimizing health care pathways for patients coming to the emergency department with high urinary tract infection.</p>","PeriodicalId":14736,"journal":{"name":"Journal de pharmacie de Belgique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36551852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Communication on smoking in community pharmacy. Results of a survey in Belgium]. 社区药房吸烟问题的沟通。比利时的一项调查结果]。
Pub Date : 2016-03-01
B Maris, P Nys

For several reasons the community pharmacist plays an important role in smoking cessation. In order to know how he is fulfilling this role, a survey was conducted among Belgian community pharmacists on smoking cessation communication in their pharmacy. The pharmacists and the pharmacy personnel were invited to answer an online questionnaire. In community pharmacy the patient is quite often asked if he smokes, however there still remain some obstacles to talk with the patient about smoking behaviour. The major obstacles are lack of time and the fear of a conflict with the patient. The results of the survey reveal that pharmacists and their assistants have a good knowledge of smoking cessation, but there is still some room to improve. In order to improve the smoking cessation support by pharmacists and their assistants, some efforts are necessary to overcome the obstacles. It would also be useful to organise more courses of tabacology at the faculties of pharmacy of the universities and in the continuing education programs for pharmacists.

出于几个原因,社区药剂师在戒烟中起着重要作用。为了了解他如何履行这一角色,我们在比利时社区药剂师中进行了一项关于他们药房戒烟沟通的调查。药剂师和药房工作人员被邀请回答一份在线问卷。在社区药房,病人经常被问及他是否吸烟,然而,与病人谈论吸烟行为仍然存在一些障碍。主要的障碍是缺乏时间和害怕与病人发生冲突。调查结果显示,药剂师及其助理对戒烟有较好的了解,但仍有改善的余地。为了提高药师及其助手对戒烟的支持,需要克服一些障碍。在大学药学院和药剂师继续教育项目中组织更多的烟草学课程也是有益的。
{"title":"[Communication on smoking in community pharmacy. Results of a survey in Belgium].","authors":"B Maris,&nbsp;P Nys","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>For several reasons the community pharmacist plays an important role in smoking cessation. In order to know how he is fulfilling this role, a survey was conducted among Belgian community pharmacists on smoking cessation communication in their pharmacy. The pharmacists and the pharmacy personnel were invited to answer an online questionnaire. In community pharmacy the patient is quite often asked if he smokes, however there still remain some obstacles to talk with the patient about smoking behaviour. The major obstacles are lack of time and the fear of a conflict with the patient. The results of the survey reveal that pharmacists and their assistants have a good knowledge of smoking cessation, but there is still some room to improve. In order to improve the smoking cessation support by pharmacists and their assistants, some efforts are necessary to overcome the obstacles. It would also be useful to organise more courses of tabacology at the faculties of pharmacy of the universities and in the continuing education programs for pharmacists.</p>","PeriodicalId":14736,"journal":{"name":"Journal de pharmacie de Belgique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36552389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Prevention and treatment of Herpes Labialis]. 【唇疱疹的预防与治疗】。
Pub Date : 2016-03-01
N Duquet

Herpes labialis, more commonly known as cold sores or fever blisters, is the most common clinical manifestation of infection with Herpes simplex virus type 1. It is a highly contagious and widespread infection. Generally benign, cold sores may however disturb those who suffer from them, because of the symptoms they cause or their unsightly and frequent appearance. The pharmacist is often consulted to relieve cold sore recurrences. As for any request for advice, the pharmacist will assess if he can help the patient himself or if medical advice is more appropriate. Besides a possible symptomatic treatment, the pharmacist will also advise the patient to prevent recurrence and the contamination of other people.

唇疱疹,俗称唇疱疹或发热水疱,是感染1型单纯疱疹病毒最常见的临床表现。这是一种高度传染性和广泛的感染。一般来说,唇疱疹是良性的,但由于其引起的症状或其不雅观和频繁的出现,可能会困扰那些患有唇疱疹的人。经常咨询药剂师以缓解唇疱疹的复发。至于要求提供意见,药剂师会评估他是否可以亲自帮助病人,或医生建议是否更合适。除了可能的对症治疗外,药剂师还会建议患者防止复发和其他人的污染。
{"title":"[Prevention and treatment of Herpes Labialis].","authors":"N Duquet","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Herpes labialis, more commonly known as cold sores or fever blisters, is the most common clinical manifestation of infection with Herpes simplex virus type 1. It is a highly contagious and widespread infection. Generally benign, cold sores may however disturb those who suffer from them, because of the symptoms they cause or their unsightly and frequent appearance. The pharmacist is often consulted to relieve cold sore recurrences. As for any request for advice, the pharmacist will assess if he can help the patient himself or if medical advice is more appropriate. Besides a possible symptomatic treatment, the pharmacist will also advise the patient to prevent recurrence and the contamination of other people.</p>","PeriodicalId":14736,"journal":{"name":"Journal de pharmacie de Belgique","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36552388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal de pharmacie de Belgique
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1